Cervarix Hpv 16 And 18 Vaccine
KSh 5,999.00
Cervarix is a vaccine that helps protect against certain types of human papillomavirus (HPV) that can lead to cervical cancer. It is made by GlaxoSmithKline and works by stimulating the immune system to produce antibodies against these high-risk HPV types. The vaccine contains HPV-16 L1 protein and HPV-18 L1 protein, which are virus-like particles that resemble the virus but cannot cause disease. It also includes an adjuvant system to boost the immune response.
Vaccine
Why You'll Love It
Cervarix is used to prevent cervical cancer and precancerous lesions caused by HPV types 16 and 18. It is recommended for females aged 9 years and older. The vaccination schedule is different based on age: For ages 9-14: Two doses, with the second dose given 5-13 months after the first dose. For ages 15 and older: Three doses, with the second dose given 1 month after the first dose, and the third dose given 6 months after the first dose. The vaccine is given as an injection in the deltoid muscle of the upper arm.
Suggested Use
Caution
What's In It
Warning
Individuals with severe allergic reactions to any component of the Cervarix vaccine should not use it, as there is a risk of immediate allergic reactions, including anaphylaxis. Medical treatment and supervision should be available in case of a severe allergic reaction. Fainting can occur before or after vaccination due to a psychological response to the needle. Monitoring for 15 minutes after administration is recommended. Vaccination should be postponed if someone has a severe fever, but minor infections like a cold do not prevent vaccination. Those with autoimmune diseases should be cautious, as the effects of the vaccine on these conditions are not fully understood. Cervarix is not recommended during pregnancy, and women should wait at least one month after completing the vaccination schedule before getting pregnant. The immune response may be weaker in individuals with compromised immune systems. Regular cervical screening programs, such as Pap tests, should continue even after vaccination, as Cervarix does not protect against all types of HPV that can cause cervical cancer.